HIV 1 News and Research

RSS

Cannabis-based medications prove effective in relieving pain

Cannabis-based medications have been proved to relieve pain. This is the conclusion drawn by Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29-30 of Deutsches Ärzteblatt International.

7 Aug 2012

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

The anti-HIV drugs, also known as anti-retroviral therapy, came about in the mid ‘90’s. These involved using at least 3 different drugs together.

7 Aug 2012

IPS reports on efforts to prevent mother-to-child HIV transmission at public hospital in Cameroon

"For nearly two years, not a single child with HIV has been born at the public hospital in the Cite-Verte district of Yaounde, the capital of Cameroon," Inter Press Service reports, adding, "Emilien Fouda, the hospital's director, says this proud record is the result of combined effort by his staff and community support groups."

7 Aug 2012

Vorinostat drives HIV from hiding

The addition of vorinostat to current antiretroviral therapy regimens can potentially help to eradicate hidden pockets of dormant human immunodeficiency virus, according to study results published in Nature.

6 Aug 2012

Clinton expresses concern over HIV in Uganda, stops in Malawi on 11-day African tour

U.S. Secretary of State Hillary Clinton "expressed concern" over Uganda's increasing number of HIV infections on a visit to the country last week, part of an 11-day trip to eight African nations, Uganda's New Vision reports (Mukasa, 8/4).

6 Aug 2012

U.N. urges Philippines to pass reproductive health bill amid protests from Catholic Church

"The United Nations has urged the Philippines to pass a bill that will allow the government to provide free contraceptives," BBC News reports (8/5).

6 Aug 2012

Blog examines impact of adolescent pregnancy in South Asia

As part of its monthly series Stories Behind the Statistics, "guest edited by FHI 360 on behalf of USAID'S IYWG, which provides technical leadership to improve the reproductive and sexual health of young people," the Bill & Melinda Gates Foundation's "Impatient Optimists" blog features a story by Gaj Bahadur Gurung, program coordinator for the National Federation of Women Living with HIV and AIDS in Nepal, who discusses the impact of adolescent pregnancy on girls and young women in South Asia.

6 Aug 2012

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

6 Aug 2012

Science magazine recaps issues discussed at AIDS 2012

Science looks back at the XIX International AIDS Conference (AIDS 2012), which ended last week in Washington, D.C., writing, "The battle against HIV is having more success than ever. ... But several presentations made clear that a gulf separates aspirations from reality when it comes to 'ending AIDS,' which [Secretary of State Hillary] Clinton and many other prominent speakers at the conference emphasized was now possible."

3 Aug 2012

Panel discussion looks back on AIDS 2012, explores possible topics for AIDS 2014

Devex reports on a panel discussion held in Washington, D.C. Wednesday during which experts "looked back at the main surprises of the just-concluded [XIX International AIDS Conference (AIDS 2012)], and offered predictions on what the 2014 follow-up [in Melbourne, Australia] will focus on."

3 Aug 2012

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

Gilead Sciences Inc. announced Thursday that it plans to partner with Mylan Inc., Ranbaxy Laboratories Ltd. and Strides Arcolab Ltd. "to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine in developing countries," the Wall Street Journal reports.

3 Aug 2012

Examining the role of collaborative partnerships in global response to HIV/AIDS

In this post in the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Rhonda Zygocki, executive vice president of policy and planning at Chevron, responds to questions about Chevron's presence at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., last week, writing that such questions "give me an opportunity to talk about the critical role everyone plays in the global fight against this epidemic, including Chevron, as well as the ways collaborative partnerships will lead to the elimination of AIDS."

3 Aug 2012

TAT-ARC fusion protein helps treat acute liver failure

Acute liver failure is a life-threatening disease, characterized by a sudden, massive death of liver cells. Unfortunately, few treatment options exist, especially for advanced-stage liver failure. As a last resort a liver transplant may be the only remaining option.

3 Aug 2012

Generic drugs saved U.S. $1T over 10 years, industry study finds

Generic drug makers released a study Thursday that found generic pharmaceuticals have saved the U.S. -- through private prescriptions as well as Medicare and Medicaid -- more than $1 trillion over 10 years.

3 Aug 2012

Investment in health systems 'a critical prerequisite' in beginning to end AIDS

The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., "ignited momentum to shift from 'fighting AIDS' to 'ending AIDS,'" Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece.

3 Aug 2012

Examining the role of economists in global health

In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, reports on the contribution of economists to the global health field, writing, "Economists are not global health's most popular human resource.

3 Aug 2012

Birth control coverage mandate impacts doctors, women, religious groups

Physicians say they -- rather than insurers -- will feel the burden of the rule. Meanwhile, Republicans in Congress stay relatively quiet on the requirement, but tensions continue among Catholics and evangelical Protestants.

3 Aug 2012

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

The once-daily integrase inhibitor dolutegravir has shown promise in a phase III noninferiority study comparing it with twice-daily raltegravir for treatment of HIV-1, indicate study results presented at the 19th International AIDS Conference in Washington DC, USA.

3 Aug 2012

Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies

Mylan Inc. today announced the establishment of a new agreement between its subsidiary Mylan Laboratories Limited and Gilead Sciences Inc. Under this agreement, Mylan has licensed the rights to produce and market generic versions of Gilead HIV/AIDS therapies containing Emtricitabine, including single and fixed-dose combinations.

3 Aug 2012

Change in drug policy needed to reverse HIV/AIDS epidemic in Eastern Europe, Central Asia

Noting the United Nations last week announced the appointment of Dr. Michel Kazatchkine, the former head of the Global Fund to Fight AIDS, Tuberculosis and Malaria, as the U.N. Secretary-General's new special envoy for HIV/AIDS in Eastern Europe and Central Asia," Kasia Malinowska-Sempruch, director of the Open Society Foundations' global drug policy program, writes in this Huffington Post opinion piece.

3 Aug 2012

HIV 1 News and Research

Cannabis-based medications prove effective in relieving pain

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

IPS reports on efforts to prevent mother-to-child HIV transmission at public hospital in Cameroon

Vorinostat drives HIV from hiding

Clinton expresses concern over HIV in Uganda, stops in Malawi on 11-day African tour

U.N. urges Philippines to pass reproductive health bill amid protests from Catholic Church

Blog examines impact of adolescent pregnancy in South Asia

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Science magazine recaps issues discussed at AIDS 2012

Panel discussion looks back on AIDS 2012, explores possible topics for AIDS 2014

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

Examining the role of collaborative partnerships in global response to HIV/AIDS

TAT-ARC fusion protein helps treat acute liver failure

Generic drugs saved U.S. $1T over 10 years, industry study finds

Investment in health systems 'a critical prerequisite' in beginning to end AIDS

Examining the role of economists in global health

Birth control coverage mandate impacts doctors, women, religious groups

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

Mylan licenses rights to produce and market generic versions of Gilead HIV/AIDS therapies

Change in drug policy needed to reverse HIV/AIDS epidemic in Eastern Europe, Central Asia

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News